Enabling tomorrow’s leaders to overcome today’s challenges

How we add value

As a venture investor with a track record of producing strong results, our firm is as dedicated and passionate about creating value as the innovators we fund. With our deep-rooted industry knowledge, hands-on experience, and commitment to social responsibility, we help tomorrow’s healthcare leaders overcome the inevitable challenges and transform visions into successful and sustainable enterprises. Supported by a talented team of professionals and a carefully chosen network of financial and strategic partners, we forge collaborative relationships that are designed for growth.

Our value-add capabilities

As sparring partners to the top management team we provide guidance especially on:  

  • Planning business milestones and strategic direction
  • Strengthening team competences
  • Preparing commerical expansion and internationalization
  • Defining and focusing on key priorities
  • Evaluating buy and build strategies
  • Reinforcing governance and internal processes
  • Identifying ESG risk and opportunities
  • Formulating financial plans and exit scenarios

How we work

As long-term investors and strategic partners to healthtech innovators, we understand that our success depends on mutual trust and an unwavering responsibility to those we work with. Our core values, which guide us in interactions with all our stakeholders and serve as the cornerstones of everything we do, are as follows:

Related information

About us

About us

MTIP is a pan-European Healthtech growth investor, based in Basel Switzerland. We invest in digitally-connected, decentralized and patient-centric medical technology leaders, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with our portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors.

Read more